1244 ET - This year's cough, cold and flu season isn't living up to Helen of Troy's expectations. "The global illness season will be well below historical averages," CFO Brian Grass says on a call with analysts. The company--with a portfolio that includes healthcare and home-comfort products such as Honeywell humidifiers and Vicks thermometers, as well as houseware brands Hydro Flask and OXO--lowered its outlook, in part due to a $15-million to $20-million headwind it expects in 4Q from the weak winter and illness season globally. "While there is the possibility that illness incidents could increase, we do not expect retailers to place meaningful, incremental replenishment orders as we are now roughly midway through the season," Grass says. Shares fall 4.8%. (connor.hart@wsj.com)
(END) Dow Jones Newswires
January 08, 2025 12:44 ET (17:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.